Supreme Court holds generics maker Hikma not liable for induced infringement: inducement must be “clear” and “affirmative”

Context: About six weeks ago, the Supreme Court of the United States (SCOTUS) heard generics maker Hikma’s appeal of a decision by the United States Court of Appeals for the Federal Circuit that sided with patent holder Amarin (April 30, 2026 ip fray article). The Federal Circuit had overruled a district court’s dismissal of Amarin’s complaint.